Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -68.61%200.04K | 98.93%389.61K | 136.28%1.16M | 94.25%379.9K | -117.19%-48.55K | 173.37%637.25K | 189.71%195.85K | -74.51%492.81K | 789.23%195.57K | -23.13%282.44K |
| Net income from continuing operations | 145.75%174.63K | 677.57%97.71K | 75.14%-52.38K | 41.61%-95.9K | 22.62%-40.11K | -4.95%71.06K | 118.11%12.57K | -136.67%-210.68K | -3,413.24%-164.24K | -172.06%-51.83K |
| Depreciation and amortization | -7.45%285.9K | -7.63%285.8K | -4.12%1.22M | -7.17%295.01K | -5.02%306.73K | -3.99%308.91K | -0.21%309.41K | 9.90%1.27M | -5.88%317.79K | 18.89%322.93K |
| Remuneration paid in stock | --0 | -50.00%-30K | -50.00%-30K | 50.00%-10K | --0 | --0 | ---20K | -140.00%-20K | ---20K | --0 |
| Deferred tax | 140.19%65.49K | 598.86%36.84K | 119.94%18.07K | 99.63%-286 | 19.89%-14.18K | -4.19%27.27K | 121.11%5.27K | -134.65%-90.62K | -293.03%-76.4K | -2,684.38%-17.7K |
| Other non cashItems | -33.93%15.82K | -41.73%17.76K | 27.05%187.03K | 149.62%114.02K | -43.82%18.6K | -33.83%23.94K | -5.53%30.47K | 3.30%147.21K | 66.73%45.68K | -30.36%33.11K |
| Change In working capital | -255.80%-300.87K | 188.79%125.97K | 12.52%-131.29K | 17.47%107.06K | -225.22%-289.59K | 796.77%193.12K | 68.10%-141.87K | 48.25%-150.08K | 121.74%91.14K | 167.04%231.27K |
| -Change in receivables | -360.00%-312.55K | 160.63%172.23K | -8,695.17%-552.07K | -153.26%-124.89K | -131.74%-75.18K | -282.38%-67.95K | 43.44%-284.05K | 159.12%6.42K | 326.75%234.5K | 145.76%236.86K |
| -Change in inventory | -92.83%21.23K | -311.81%-75.29K | 106.49%21.34K | 165.14%122.86K | -181.93%-432.98K | 1,108.74%295.9K | 118.49%35.55K | -391.75%-328.85K | 373.74%46.34K | -191.54%-153.58K |
| -Change in prepaid assets | -223.22%-119.63K | 159.90%56.29K | -141.22%-123.09K | -277.69%-149.62K | 141.98%23.42K | 12.53%97.09K | -151.10%-93.98K | 192.22%298.59K | 136.27%84.2K | -18.39%-55.78K |
| -Change in payables and accrued expense | 183.44%110.09K | -113.59%-27.27K | 513.90%522.53K | 194.45%258.7K | -4.23%195.15K | -8.21%-131.93K | 204.88%200.62K | -85.37%-126.25K | -309.83%-273.91K | 256.24%203.78K |
| Tax refund paid | -415.92%-40.93K | ---144.46K | 89.67%-47.04K | -1,965.73%-30K | 87.25%-30K | 106.47%12.96K | --0 | -682.30%-455.56K | 107.48%1.61K | -994.06%-235.33K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -68.61%200.04K | 98.94%389.61K | 136.28%1.16M | 94.25%379.9K | -117.19%-48.55K | 173.37%637.25K | 189.71%195.85K | -74.51%492.81K | 789.23%195.57K | -23.13%282.44K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 34.39%-58.9K | -197.34%-73.72K | 42.32%-236.77K | 51.73%-43.27K | -45.65%-78.94K | 11.86%-89.76K | 84.96%-24.79K | 5.05%-410.5K | 7.89%-89.65K | 61.45%-54.2K |
| Net PPE purchase and sale | 34.39%-58.9K | -197.34%-73.72K | 42.32%-236.77K | 51.73%-43.27K | -45.65%-78.94K | 11.86%-89.76K | 84.96%-24.79K | 5.05%-410.5K | 7.89%-89.65K | 61.45%-54.2K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 34.39%-58.9K | -197.34%-73.72K | 42.32%-236.77K | 51.73%-43.27K | -45.65%-78.94K | 11.86%-89.76K | 84.96%-24.79K | 5.05%-410.5K | 7.89%-89.65K | 61.45%-54.2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 82.56%-91.15K | 2.22%-231.72K | -1,899.31%-895.41K | -321.48%-245.3K | 141.42%109.63K | -906.72%-522.77K | -171.81%-236.97K | 97.36%-44.79K | 77.47%-58.2K | 43.15%-264.66K |
| Net issuance payments of debt | 84.95%-75.06K | -3.01%-219.22K | -943.53%-806.84K | -1,723.63%-223.76K | 155.41%128.3K | -3,114.55%-498.58K | -159.95%-212.81K | 109.32%95.65K | 94.68%-12.27K | 3.56%-231.54K |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | 33.48%-16.09K | 48.27%-12.5K | 36.93%-88.57K | 53.09%-21.55K | 43.63%-18.67K | 33.57%-24.19K | 3.22%-24.16K | -4.23%-140.44K | -66.18%-45.93K | 29.99%-33.12K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 82.56%-91.15K | 2.22%-231.72K | -1,899.31%-895.41K | -321.48%-245.3K | 141.42%109.63K | -906.72%-522.77K | -171.81%-236.97K | 97.36%-44.79K | 77.47%-58.2K | 43.15%-264.66K |
| Net cash flow | ||||||||||
| Beginning cash position | 404.47%227.44K | 29.07%143.27K | 51.08%111K | -71.67%51.94K | -29.98%69.8K | 121.56%45.09K | 51.04%111K | -72.59%73.47K | -90.49%183.32K | -85.68%99.69K |
| Current changes in cash | 102.27%49.99K | 227.70%84.18K | -14.03%32.27K | 91.29%91.33K | 50.96%-17.86K | -68.85%24.72K | -24.04%-65.92K | 119.29%37.53K | 112.43%47.74K | 84.75%-36.41K |
| End cash Position | 297.47%277.43K | 404.47%227.44K | 29.07%143.27K | 29.07%143.27K | -17.91%51.94K | -29.98%69.8K | 121.56%45.09K | 51.08%111K | 51.08%111K | -86.17%63.28K |
| Free cash from | -74.22%141.14K | 84.67%315.89K | 1,026.97%927.68K | 217.80%336.63K | -155.86%-127.49K | 317.07%547.48K | 144.65%171.06K | -94.52%82.32K | 184.27%105.93K | 0.62%228.25K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.